Data spanning the past 90 days through February 19, 2026 reveals that Armata Pharmaceuticals's three principal insider shareholders consist of Director Inc. Innoviva, (16.37Mn shares), Chief Executive Officer Deborah Birx (217.38K shares), Chief Business Officer Pierre Kyme (10.49K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Inc. Innoviva, | 16,365,969 | 01 Apr, 2022 | |
| Deborah Birx | Chief Executive Officer | 217,377 | 14 Jul, 2025 |
| Pierre Kyme | Chief Business Officer | 10,491 | 25 Apr, 2025 |
| Richard Rychlik | Corporate Controller And Pfo | 10,000 | 18 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Jul, 2025 | Deborah Birx | Common Stock | D | 13,637 | $2.27 | 217,377 | D | F |
| 14 Mar, 2025 | Pierre Kyme | Common Stock | D | 1,027 | $1.95 | 10,491 | D | F |
| 14 Mar, 2025 | Pierre Kyme | - | - | 10,491 | D | |||
| 14 Mar, 2024 | Deborah Birx | Common Stock | A | 60,000 | $0.00 | 260,000 | D | A |
| 14 Mar, 2024 | Richard Rychlik | - | - | 10,000 | D | |||
| 14 Mar, 2024 | Richard Rychlik | Common Stock | A | 10,000 | $0.00 | 10,000 | D | A |
| 21 Dec, 2023 | Deborah Birx | Common Stock | A | 200,000 | $0.00 | 200,000 | D | A |
| 31 Mar, 2022 | Inc. Innoviva, | Common Stock | A | 5,385,208 | $5.00 | 16,365,969 | I | P |
| 09 Feb, 2022 | Inc. Innoviva, | Common Stock | A | 3,614,792 | $5.00 | 10,980,761 | I | P |
| 09 Feb, 2022 | Inc. Innoviva, | - | - | 10,980,761 | I | |||
| 29 Oct, 2021 | Inc. Innoviva, | Common Stock | A | 1,212,122 | $3.30 | 7,365,969 | I | P |
| 17 Mar, 2021 | Inc. Innoviva, | Common Stock | A | 4,285,935 | $3.25 | 6,153,847 | I | P |
| 26 Jan, 2021 | Inc. Innoviva, | Common Stock | A | 1,867,912 | $3.25 | 1,867,912 | I | P |
| 27 Mar, 2020 | Inc. Innoviva, | Common Stock | A | 7,717,661 | $2.87 | 8,710,800 | D | P |
| 27 Mar, 2020 | Inc. Innoviva, | - | - | 8,710,800 | D | |||
| 08 Dec, 2017 | Paul C Grint | - | - | 43 | D | |||
| 08 Dec, 2017 | Paul C Grint | Common Stock | A | 599 | $0.62 | 43 | D | A |
| 29 Dec, 2016 | Randal J Kirk | Common Stock | D | 20,077 | $0.45 | 344 | I | S |
| 29 Dec, 2016 | Randal J Kirk | Common Stock | D | 21,923 | $0.45 | 376 | I | S |
| 29 Dec, 2016 | Randal J Kirk | - | - | 376 | I |